Elagolix0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Elagolix — research data
Regulatory statusFDA-approved (Orilissa)
NCAA D1Banned
Overview
About Elagolix
Mechanism of action
Oral non-peptide GnRH receptor antagonist; dose-dependent estradiol suppression
Safety profile
Hot flashes, night sweats, bone density loss · Approved for endometriosis; bone loss with prolonged use; hepatotoxicity warning
Related pages